These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 29641293)

  • 1. Integrated BioTherapeutics.
    Aman MJ
    Hum Vaccin Immunother; 2018 Jun; 14(6):1308-1310. PubMed ID: 29641293
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter from the editor.
    Ellis RW; Riedmann EM
    Hum Vaccin Immunother; 2012 Mar; 8(3):281. PubMed ID: 22418878
    [No Abstract]   [Full Text] [Related]  

  • 3. Known unknowns and unknown unknowns.
    Burki T
    Lancet Infect Dis; 2018 Apr; 18(4):385-386. PubMed ID: 29582769
    [No Abstract]   [Full Text] [Related]  

  • 4. Making vaccines "on demand": a potential solution for emerging pathogens and biodefense?
    De Groot AS; Einck L; Moise L; Chambers M; Ballantyne J; Malone RW; Ardito M; Martin W
    Hum Vaccin Immunother; 2013 Sep; 9(9):1877-84. PubMed ID: 23877094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccinology in the 21st century-The 10th Annual Vaccine Congress.
    Kostova EB; Poland GA
    Vaccine; 2017 Aug; 35(35 Pt A):4451-4452. PubMed ID: 28720282
    [No Abstract]   [Full Text] [Related]  

  • 6. Second coming: the re-emergence and modernization of immunotherapy by vaccines as a component of leprosy control.
    Duthie MS; Casper C; Reed SG
    Future Microbiol; 2018 Oct; 13():1449-1451. PubMed ID: 30311780
    [No Abstract]   [Full Text] [Related]  

  • 7. Monoclonal Antibodies for Emerging Infectious Diseases - Borrowing from History.
    Marston HD; Paules CI; Fauci AS
    N Engl J Med; 2018 Apr; 378(16):1469-1472. PubMed ID: 29513615
    [No Abstract]   [Full Text] [Related]  

  • 8. Vaccines We Need But Don't Have.
    Plotkin SA
    Viral Immunol; 2018 Mar; 31(2):114-116. PubMed ID: 29131713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-disseminating vaccines for emerging infectious diseases.
    Murphy AA; Redwood AJ; Jarvis MA
    Expert Rev Vaccines; 2016; 15(1):31-9. PubMed ID: 26524478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of systems biology approaches in determining molecular signatures for the development of more effective vaccines.
    Pezeshki A; Ovsyannikova IG; McKinney BA; Poland GA; Kennedy RB
    Expert Rev Vaccines; 2019 Mar; 18(3):253-267. PubMed ID: 30700167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccine adjuvants: insights from industry. Interview by Jenaid Rees.
    Andréasson S
    Expert Rev Vaccines; 2013 Jul; 12(7):731-2. PubMed ID: 23885818
    [No Abstract]   [Full Text] [Related]  

  • 12. Letter from the editor.
    Ellis R; Weiss A
    Hum Vaccin Immunother; 2015; 11(5):1077. PubMed ID: 26018441
    [No Abstract]   [Full Text] [Related]  

  • 13. Outbreak response as an essential component of vaccine development.
    Hatchett R; Lurie N
    Lancet Infect Dis; 2019 Nov; 19(11):e399-e403. PubMed ID: 31256955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Questions for biotechs.
    Bachmann M
    Hum Vaccin; 2010 Jul; 6(7):527. PubMed ID: 20622523
    [No Abstract]   [Full Text] [Related]  

  • 15. Vero cell technology for rapid development of inactivated whole virus vaccines for emerging viral diseases.
    Barrett PN; Terpening SJ; Snow D; Cobb RR; Kistner O
    Expert Rev Vaccines; 2017 Sep; 16(9):883-894. PubMed ID: 28724343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Special focus: Asia endemic diseases.
    Ellis R; Weiss A
    Hum Vaccin Immunother; 2015; 11(5):1075-6. PubMed ID: 26018440
    [No Abstract]   [Full Text] [Related]  

  • 17. Letter from the editor.
    Ellis R; Riedmann EM
    Hum Vaccin Immunother; 2013 Apr; 9(4):721. PubMed ID: 24091588
    [No Abstract]   [Full Text] [Related]  

  • 18. Tenth World Congress on Vaccines, Immunisation and Immunotherapy.
    Kurstak E
    Hum Vaccin Immunother; 2017 Feb; 13(2):253-254. PubMed ID: 27925509
    [No Abstract]   [Full Text] [Related]  

  • 19. New frontiers in drug development utilizing desorption by impulsive vibrational excitation for sample preparation, tissue imaging and beyond.
    Robertson WD; Schlüter H; Miller RD; Ji QC
    Bioanalysis; 2018 Oct; 10(20):1625-1629. PubMed ID: 30354194
    [No Abstract]   [Full Text] [Related]  

  • 20. Innovative vaccine production technologies: the evolution and value of vaccine production technologies.
    Bae K; Choi J; Jang Y; Ahn S; Hur B
    Arch Pharm Res; 2009 Apr; 32(4):465-80. PubMed ID: 19407962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.